๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Wuhan
Clinical trial register · China

Clinical Trials in Wuhan, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Wuhan 21 Huangshi 2 Jingzhou 2 Xiangyang 2 Yichang 1
Narrow the registerReset
Recruitment status
Phase
Site location
Wuhan21 Huangshi2 Jingzhou2 Xiangyang2 Yichang1
All 9 locations
Target enrolment
to

Trials with a site in Wuhan

21 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
Early Diagnosis Model of Colorectal Adenoma Using Laboratory Examinations
NCT07793110Colorectal Adenoma, Polyp
Renmin Hospital of Wuhan University
Observational
400
Wuhan
2026-09-01
Active, closed
A Prospective Study of Cold Exposure in Patients With MASH
NCT07821749Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Renmin Hospital of Wuhan University
Not applicable
11
Wuhan
2026-07-08
Recruiting
Low-Intensity Focused Ultrasound Targeting the Stellate Ganglion for Regulating Autonomic Nerve Function and Sleep Quality in Perioperative Patients With Cardiovascular Diseases
NCT07595068Atrial Fibrillation (AF), Cardiovascular Diseases
Renmin Hospital of Wuhan University
Not applicable
200
Huangshi, Jingzhou, Wuhan, Xiangyang, Yichang
2026-05-20
Recruiting
Efficacy and Safety of Ultrasound Modulation of Stellate Ganglion for the Prevention of Ventricular Arrhythmia in Patients With ST-segment Elevation Myocardial Infarction
NCT07587294Acute ST-segment Elevation Myocardial Infarction (Patients Undergoing Emergency PCI)
Renmin Hospital of Wuhan University
Not applicable
100
Huangshi, Jingzhou, Shiyan, Wuhan, Xiangyang
2026-05-15
Recruiting
Digital Out-of-hospital Management on Clinical Outcomes in Patients With Early Cardiogenic Shock
NCT07085221Shock, Cardiogenic, Shock
Renmin Hospital of Wuhan University
Not applicable
472
Wuhan
2025-07-26
Not yet open
The Efficacy and Safety of Treatment With Telitacicept in Primary Membranous Nephropathy
NCT06614985Primary Membranous Nephropathy
Renmin Hospital of Wuhan University
Phase 2
172
Wuhan
2024-10-20
Active, closed
The Efficacy and Safety of Treatment with Telitacicept in Antineutrophil Cytoplasmic Antibody-associated Nephritis (AAGN)
NCT06656962Antineutrophil Cytoplasmic Antibody (ANCA)-associated Nephritis (AAGN)
Renmin Hospital of Wuhan University
Phase 1/2
15
Wuhan
2024-10-10
Recruiting
Artificial Intelligence-assisted System in Colonoscopy
NCT06406062Adenoma Colon Polyp
Renmin Hospital of Wuhan University
Observational
7,500
Wuhan
2024-05-20
Recruiting
Metabolomic Profile of Vitreoretinal Diseases: an NMR-Based Approach Using Vitreous.
NCT06429969Vitreoretinal Disease
Renmin Hospital of Wuhan University
Observational
450
Wuhan
2024-01-17
Recruiting
Wuhan High Myopia Study
NCT06162234High Myopia
Renmin Hospital of Wuhan University
Observational
1,000
Wuhan
2023-12-25
Recruiting
Application Evaluation Research on the Artificial Intelligence-assisted Support System for the Diagnosis of Colorectal Tubular Adenoma Lesions
NCT07073430Colorectal Adenoma, Artificial Intelligence (AI)
Renmin Hospital of Wuhan University
Observational
4,000
Wuhan
2023-11-28
Recruiting
Effect of the Automatic Surveillance System on Surveillance Rate of Patients with Gastric Premalignant Lesions
NCT06039917Artificial Intelligence, Surveillance
Renmin Hospital of Wuhan University
Not applicable
1,460
Quanzhou, Wuhan, Shanghai
2023-09-10
Recruiting
A Study of Chemoradiation in Combination with Tislelizumab As First Line Treatment in Participants with Advanced Esophageal Squamous Cell Carcinoma
NCT05919030Esophageal Squamous Cell Carcinoma
Renmin Hospital of Wuhan University
Phase 3
155
Wuhan
2023-07-01
Not yet open
Effect of the Automatic Surveillance System on Surveillance Rate of Colorectal Postpolypectomy Patients
NCT05894850Artificial Intelligence, Surveillance
Renmin Hospital of Wuhan University
Not applicable
1,644
Wuhan
2023-06-01
Recruiting
Influence Mechanism of Tumor Microenvironment Changes on Neoadjuvant Therapy for Esophageal Squamous Cell Carcinoma
NCT05894369Esophageal Cancer
Renmin Hospital of Wuhan University
Observational
10
Wuhan
2023-05-04
Not yet open
Evaluating the Effect of the Automatic Surveillance System on Surveillance Rate of Colorectal Postpolypectomy Patients
NCT05751824Artificial Intelligence, Surveillance
Renmin Hospital of Wuhan University
Not applicable
867
Jiangmen, Wuhan
2023-02-26
Not yet open
Genetic and Epigenetic Determinants of Response to Fluorouracil-based Adjuvant Chemotherapy in Patients With Stage III Colorectal Cancer
NCT03127111Stage III Colorectal Cancer
Renmin Hospital of Wuhan University
Observational
300
Wuhan
2022-12-01
Recruiting
Short-course Radiotherapy Combined With Neoadjuvant Chemotherapy and PD-1 Inhibitor in the Treatment of Locally Advanced Gastric Adenocarcinoma
NCT05563012Disorder in Complete Remission in Response to Treatment
Renmin Hospital of Wuhan University
Phase 2
29
Wuhan
2022-09-26
Recruiting
Multicenter Study on Postoperative Urinary and Sexual Function During Laparoscopic Functional Total Mesorectum Excision
NCT05049317Rectal Cancer
Renmin Hospital of Wuhan University
Not applicable
88
Wuhan
2021-11-24
Recruiting
Samples Procurement for Colorectal Cancer, Gastric Cancer, and Non-malignant Disease
NCT03972956Colorectal Cancer, Gastric Cancer, Inflammatory Bowel Diseases, Gastric Ulcer
Renmin Hospital of Wuhan University
Observational
1,000
Wuhan
2020-12-23
Rows per page Showing 1–21 of 21
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 26 September 2026. https://priyalifescience.com/clinical-trials-china/city/wuhan

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 21 of those studies with a site in Wuhan that also match the filters currently applied.

How many clinical trials are recruiting in Wuhan?

13 of the 21 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 6 have not yet opened recruitment, 2 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Wuhan), 21 studies
PhaseStudiesRecruitingShare
Not applicable9542.9%
Observational8638.1%
Phase 2219.5%
Phase 1/2104.8%
Phase 3114.8%

Most active sponsors

Lead sponsors with the most studies (Wuhan)
Lead sponsorStudiesRecruiting
Renmin Hospital of Wuhan University2113
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.